Search

Amy Jo Sterling

Examiner (ID: 4242, Phone: (571)272-6823 , Office: P/3631 )

Most Active Art Unit
3631
Art Unit(s)
3632, 3631
Total Applications
2801
Issued Applications
2050
Pending Applications
118
Abandoned Applications
672

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1230428 [patent_doc_number] => 06692748 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2' [patent_app_type] => B2 [patent_app_number] => 10/012605 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42430 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/692/06692748.pdf [firstpage_image] =>[orig_patent_app_number] => 10012605 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/012605
Adipocyte complement related protein zacrp3x2 and nucleic acids encoding zacrp3x2 Dec 6, 2001 Issued
Array ( [id] => 6750942 [patent_doc_number] => 20030045463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/990437 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 331 [patent_figures_cnt] => 331 [patent_no_of_words] => 290704 [patent_no_of_claims] => 118 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045463.pdf [firstpage_image] =>[orig_patent_app_number] => 09990437 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/990437
Secreted and transmembrane polypeptides and nucleic acids encoding the same Nov 15, 2001 Abandoned
Array ( [id] => 928311 [patent_doc_number] => 07314619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-01 [patent_title] => 'Inducing apoptosis using anti-Apo-2 antibodies' [patent_app_type] => utility [patent_app_number] => 10/052798 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 34 [patent_no_of_words] => 31851 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/314/07314619.pdf [firstpage_image] =>[orig_patent_app_number] => 10052798 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/052798
Inducing apoptosis using anti-Apo-2 antibodies Nov 1, 2001 Issued
Array ( [id] => 993813 [patent_doc_number] => 06916913 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Dorsalin-1 polypeptide and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/002278 [patent_app_country] => US [patent_app_date] => 2001-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 47 [patent_no_of_words] => 14765 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916913.pdf [firstpage_image] =>[orig_patent_app_number] => 10002278 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/002278
Dorsalin-1 polypeptide and uses thereof Nov 1, 2001 Issued
Array ( [id] => 724005 [patent_doc_number] => 07045318 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-16 [patent_title] => 'Recombinant fusion proteins to growth hormone and serum albumin' [patent_app_type] => utility [patent_app_number] => 09/984010 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 12 [patent_no_of_words] => 6863 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/045/07045318.pdf [firstpage_image] =>[orig_patent_app_number] => 09984010 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/984010
Recombinant fusion proteins to growth hormone and serum albumin Oct 25, 2001 Issued
Array ( [id] => 6560499 [patent_doc_number] => 20020164701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Human gene marker for metabolic disease' [patent_app_type] => new [patent_app_number] => 10/001631 [patent_app_country] => US [patent_app_date] => 2001-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29906 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164701.pdf [firstpage_image] =>[orig_patent_app_number] => 10001631 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/001631
Human gene marker for metabolic disease Oct 24, 2001 Abandoned
Array ( [id] => 7673381 [patent_doc_number] => 20040180398 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Mammalian secretory protein Zsig43' [patent_app_type] => new [patent_app_number] => 10/033388 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29691 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180398.pdf [firstpage_image] =>[orig_patent_app_number] => 10033388 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/033388
Mammalian secretory protein Zsig43 Oct 23, 2001 Abandoned
Array ( [id] => 6874447 [patent_doc_number] => 20030194744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/017086 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 238 [patent_figures_cnt] => 238 [patent_no_of_words] => 192313 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20030194744.pdf [firstpage_image] =>[orig_patent_app_number] => 10017086 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/017086
PRO274 nucleic acids Oct 23, 2001 Issued
Array ( [id] => 7678992 [patent_doc_number] => 20030195344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/999829 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 237 [patent_figures_cnt] => 237 [patent_no_of_words] => 192762 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20030195344.pdf [firstpage_image] =>[orig_patent_app_number] => 09999829 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/999829
Secreted and transmembrane polypeptides and nucleic acids encoding the same Oct 23, 2001 Abandoned
Array ( [id] => 6526963 [patent_doc_number] => 20020192706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 09/999832 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 238 [patent_figures_cnt] => 238 [patent_no_of_words] => 192469 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192706.pdf [firstpage_image] =>[orig_patent_app_number] => 09999832 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/999832
PRO273 polypeptides Oct 23, 2001 Issued
Array ( [id] => 6721528 [patent_doc_number] => 20030055218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Human receptor proteins; related reagents and methods' [patent_app_type] => new [patent_app_number] => 10/011548 [patent_app_country] => US [patent_app_date] => 2001-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35226 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055218.pdf [firstpage_image] =>[orig_patent_app_number] => 10011548 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/011548
Human receptor proteins; related reagents and methods Oct 21, 2001 Abandoned
09/890053 Pharmaceutical composition of hydrophobically modified hedgehog protein and their use Oct 18, 2001 Abandoned
Array ( [id] => 1247516 [patent_doc_number] => 06673343 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-06 [patent_title] => 'SAL-S1 receptor protein tyrosine kinase agonist antibodies' [patent_app_type] => B2 [patent_app_number] => 09/982610 [patent_app_country] => US [patent_app_date] => 2001-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 61 [patent_no_of_words] => 17061 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673343.pdf [firstpage_image] =>[orig_patent_app_number] => 09982610 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/982610
SAL-S1 receptor protein tyrosine kinase agonist antibodies Oct 16, 2001 Issued
Array ( [id] => 5739242 [patent_doc_number] => 20060009633 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2006-01-12 [patent_title] => 'Complementary DNAs encoding proteins with signal peptides' [patent_app_type] => utility [patent_app_number] => 09/978360 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 104854 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0009/20060009633.pdf [firstpage_image] =>[orig_patent_app_number] => 09978360 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/978360
Complementary DNAs encoding proteins with signal peptides Oct 14, 2001 Abandoned
Array ( [id] => 5739242 [patent_doc_number] => 20060009633 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2006-01-12 [patent_title] => 'Complementary DNAs encoding proteins with signal peptides' [patent_app_type] => utility [patent_app_number] => 09/978360 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 104854 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0009/20060009633.pdf [firstpage_image] =>[orig_patent_app_number] => 09978360 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/978360
Complementary DNAs encoding proteins with signal peptides Oct 14, 2001 Abandoned
Array ( [id] => 938496 [patent_doc_number] => 06972325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-06 [patent_title] => 'PRO273 polypeptides' [patent_app_type] => utility [patent_app_number] => 09/978189 [patent_app_country] => US [patent_app_date] => 2001-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 237 [patent_figures_cnt] => 237 [patent_no_of_words] => 190011 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972325.pdf [firstpage_image] =>[orig_patent_app_number] => 09978189 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/978189
PRO273 polypeptides Oct 14, 2001 Issued
Array ( [id] => 1173226 [patent_doc_number] => 06746674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-08 [patent_title] => 'Cytostatin II' [patent_app_type] => B2 [patent_app_number] => 09/971187 [patent_app_country] => US [patent_app_date] => 2001-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18295 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/746/06746674.pdf [firstpage_image] =>[orig_patent_app_number] => 09971187 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/971187
Cytostatin II Oct 4, 2001 Issued
Array ( [id] => 515875 [patent_doc_number] => 07189400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-03-13 [patent_title] => 'Methods of treatment with antagonists of MU-1' [patent_app_type] => utility [patent_app_number] => 09/972218 [patent_app_country] => US [patent_app_date] => 2001-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13106 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189400.pdf [firstpage_image] =>[orig_patent_app_number] => 09972218 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/972218
Methods of treatment with antagonists of MU-1 Oct 3, 2001 Issued
Array ( [id] => 968675 [patent_doc_number] => 06939950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-09-06 [patent_title] => 'Bovine tumor necrosis factor receptor-1 and methods of use' [patent_app_type] => utility [patent_app_number] => 09/970532 [patent_app_country] => US [patent_app_date] => 2001-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6473 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/939/06939950.pdf [firstpage_image] =>[orig_patent_app_number] => 09970532 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/970532
Bovine tumor necrosis factor receptor-1 and methods of use Oct 2, 2001 Issued
Array ( [id] => 6813612 [patent_doc_number] => 20030073162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Signal peptide-containing proteins' [patent_app_type] => new [patent_app_number] => 09/968433 [patent_app_country] => US [patent_app_date] => 2001-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 22018 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073162.pdf [firstpage_image] =>[orig_patent_app_number] => 09968433 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/968433
SP16 protein Sep 30, 2001 Issued
Menu